Cargando…

Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages

An excessive, non‐resolving inflammatory response underlies severe COVID‐19 that may have fatal outcomes. Therefore, the investigation of endogenous pathways leading to resolution of inflammation is of interest to uncover strategies for mitigating inflammation in people with SARS‐CoV‐2 infection. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Recchiuti, Antonio, Patruno, Sara, Mattoscio, Domenico, Isopi, Elisa, Pomilio, Antonella, Lamolinara, Alessia, Iezzi, Manuela, Pecce, Romina, Romano, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250053/ https://www.ncbi.nlm.nih.gov/pubmed/33749902 http://dx.doi.org/10.1096/fj.202001952R

Ejemplares similares

382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins
por: Recchiuti, A., et al.
Publicado: (2021)

Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes
por: Mattoscio, Domenico, et al.
Publicado: (2021)

Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis
por: Isopi, Elisa, et al.
Publicado: (2020)

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
por: Recchiuti, Antonio, et al.
Publicado: (2019)

Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer
por: Mattoscio, Domenico, et al.
Publicado: (2022)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review
por: Romano, Mario, et al.
Publicado: (2019)

Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis
por: Eickmeier, Olaf, et al.
Publicado: (2017)

Effect of Fish Oil vs. Resolvin D1, E1, Methyl Esters of Resolvins D1 or D2 on Diabetic Peripheral Neuropathy
por: Obrosov, Alexander, et al.
Publicado: (2017)

microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A(4) receptor-dependent mechanisms of inflammation resolution and antimicrobial defense
por: Pierdomenico, Anna Maria, et al.
Publicado: (2017)

Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
por: Ferri, Giulia, et al.
Publicado: (2023)

Resolvin D1 and Aspirin-Triggered Resolvin D1 Regulate Histamine-stimulated Conjunctival Goblet Cell Secretion
por: Li, Dayu, et al.
Publicado: (2013)

17(R)‐resolvin D1 ameliorates bleomycin‐induced pulmonary fibrosis in mice
por: Yatomi, Masakiyo, et al.
Publicado: (2015)

Resolvin D2 and Resolvin D1 Differentially Activate Protein Kinases to Counter-Regulate Histamine-Induced [Ca(2+)](i) Increase and Mucin Secretion in Conjunctival Goblet Cells
por: Yang, Menglu, et al.
Publicado: (2021)

Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results
por: Navarini, Luca, et al.
Publicado: (2018)

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
por: Spite, Matthew, et al.
Publicado: (2009)

Identification of resolvin D2 receptor mediating resolution of infections and organ protection
por: Chiang, Nan, et al.
Publicado: (2015)

Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats
por: Zuo, Gang, et al.
Publicado: (2018)

Resolvin D2 suppresses NLRP3 inflammasome by promoting autophagy in macrophages
por: Cao, Lijun, et al.
Publicado: (2021)

Editorial: Specialized proresolving mediators: Benefits within and beyond inflammation resolution in cardiometabolic, neurological and psychiatric disorders
por: Sousa, Teresa, et al.
Publicado: (2023)

Resolvin D1 and D2 inhibit tumour growth and inflammation via modulating macrophage polarization
por: Shan, Kai, et al.
Publicado: (2020)

Resolvin D5 Inhibits Neuropathic and Inflammatory Pain in Male But Not Female Mice: Distinct Actions of D-Series Resolvins in Chemotherapy-Induced Peripheral Neuropathy
por: Luo, Xin, et al.
Publicado: (2019)

Resolvin D2 attenuates chronic pain–induced depression‐like behavior in mice
por: Suzuki, Hiroe, et al.
Publicado: (2021)

Excessive inflammatory response to infection in experimental peri‐implantitis: Resolution by Resolvin D2
por: Heyman, Oded, et al.
Publicado: (2022)

Association of the resolvin precursor 17-HDHA, but not D- or E- series resolvins, with heat pain sensitivity and osteoarthritis pain in humans
por: Valdes, Ana M., et al.
Publicado: (2017)

Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis
por: Totani, Licia, et al.
Publicado: (2021)

Resolvin D1 drives establishment of Leishmania amazonensis infection
por: Malta-Santos, Hayna, et al.
Publicado: (2017)

Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Moustaki, Maria, et al.
Publicado: (2017)

Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy
por: Dort, Junio, et al.
Publicado: (2021)

Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor
por: Lamolinara, Alessia, et al.
Publicado: (2015)

Influences of resolvin D1 and D2 on the risk of type 2 diabetes mellitus: a Chinese community-based cohort study
por: Sun, Qian, et al.
Publicado: (2023)

Vitamin D Deficiency in Cystic Fibrosis
por: Hall, William B., et al.
Publicado: (2010)

The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Wang, Menglong, et al.
Publicado: (2023)

Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
por: Norling, Lucy V., et al.
Publicado: (2016)

Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis Pain
por: Huang, Junting, et al.
Publicado: (2017)

Resolvin D1, therapeutic target in acute respiratory distress syndrome
por: Molaei, Emad, et al.
Publicado: (2021)

Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
por: Norling, Lucy V., et al.
Publicado: (2023)

Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs
por: Guilherme, Rafael F., et al.
Publicado: (2023)

Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells
por: Li, Longyan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_10daqolcidjuj1pa99divkhcp2